SCHEMBL4782584

SCHEMBL4782584

N[C@H](Cc1ccccn1)CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
MEN1 O00255 1/20 0.60
PKM P14618 1/20 0.60
KMT2A Q03164 1/20 0.60
HSD17B10 Q99714 1/20 0.57
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
GRIN2B Q13224 1/20 0.46
GRIN2C Q14957 1/20 0.46
GRIN3A Q8TCU5 1/20 0.46
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
DPP4 P27487 1/20 0.43
CYP1B1 Q16678 1/20 0.43
FDPS P14324 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4782581 1.00 ALDH1A1 (0.60) ALDH1A1MEN1PKMKMT2AHSD17B10
Hydrochloric Acid SCHEMBL4902418 0.99 ALDH1A1 (0.59) ALDH1A1MEN1PKMKMT2AHSD17B10
Hydrochloric Acid SCHEMBL4902414 0.99 ALDH1A1 (0.59) ALDH1A1MEN1PKMKMT2AHSD17B10
SCHEMBL20279530 0.83 KMT2A (0.55) ALDH1A1MEN1PKMKMT2AHSD17B10
SCHEMBL28589204 0.83 KMT2A (0.55) ALDH1A1MEN1PKMKMT2AHSD17B10
SCHEMBL4615361 0.78 SMN1; SMN2 (0.48) ALDH1A1MEN1PKMKMT2AMAPK1
SCHEMBL4615363 0.78 SMN1; SMN2 (0.48) ALDH1A1MEN1PKMKMT2AMAPK1
SCHEMBL22421014 0.77 HSD17B10 (0.62) ALDH1A1MEN1PKMKMT2AHSD17B10
SCHEMBL14909378 0.77 ALDH1A1 (0.53) ALDH1A1MEN1PKMKMT2AHSD17B10
SCHEMBL14923670 0.77 ALDH1A1 (0.53) ALDH1A1MEN1PKMKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287251-B2 Pyrazole derivative or pharmaceutically acceptable salt thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2019-05-14 US disclosed
WO-2018117166-A1 THIAZOLE DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT OF SAME キッセイ薬品工業株式会社 2018-06-28 WO disclosed
US-20180170879-A1 PYRAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL CO., LTD. (JP) 2018-06-21 US disclosed
US-20180170879-A1 PYRAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL CO., LTD. (JP) 2018-06-21 US disclosed
WO-2008036308-A2 AMINO-SUBSTITUTED HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2008-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287251-B2 Pyrazole derivative or pharmaceutically acceptable salt thereof TRPM8, HCN3, HCN4 ALDH1A1 2377/4885MEN1 1158/4885PKM 1967/4885
US-20180170879-A1 PYRAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TRPM8, HCN3, HCN4 ALDH1A1 1871/4885MEN1 1330/4885PKM 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.